Importance of side effects in opioid treatment: a trade-off analysis with patients and physicians.

Side effects of analgesia may significantly reduce quality of life in symptomatic multiple myeloma: a cross-sectional prevalence study. Support Care Cancer (2014) 1.53

The discovery and development of analgesics: new mechanisms, new modalities. J Clin Invest (2010) 1.03

Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodes. Am J Hematol (2011) 1.00

IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies. Clin Trials (2013) 0.96

Shared decision-making in the selection of outpatient analgesics for older individuals in the emergency department. J Am Geriatr Soc (2013) 0.94

Predictors of use of pain medications for persistent knee pain after primary Total Knee Arthroplasty: a cohort study using an institutional joint registry. Arthritis Res Ther (2012) 0.87

Effectiveness and safety of tapentadol prolonged release with tapentadol immediate release on-demand for the management of severe, chronic osteoarthritis-related knee pain: results of an open-label, phase 3b study. J Pain Res (2012) 0.85

Side effects from oral opioids in older adults during the first week of treatment for acute musculoskeletal pain. Acad Emerg Med (2013) 0.85

Pharmacotherapeutic management of chronic noncancer pain in primary care: lessons for pharmacists. J Pain Res (2014) 0.84

Oxycodone/Naloxone: role in chronic pain management, opioid-induced constipation, and abuse deterrence. Pain Ther (2014) 0.81

Self-reports of medication side effects and pain-related activity interference in patients with chronic pain: a longitudinal cohort study. Pain (2015) 0.78

Determinants for acceptance of preventive treatment against heart disease - a web-based population survey. BMC Public Health (2014) 0.77

Tapentadol extended release in the management of peripheral diabetic neuropathic pain. Ther Clin Risk Manag (2015) 0.75

Health Care Utilization and Costs Associated with Nausea and Vomiting in Patients Receiving Oral Immediate-Release Opioids for Outpatient Acute Pain Management. Pain Ther (2016) 0.75

Four Strategies for Managing Opioid-Induced Side Effects in Older Adults. Clin Geriatr (2013) 0.75

A phase 3, randomized, double-blind comparison of analgesic efficacy and tolerability of Q8003 vs oxycodone or morphine for moderate-to-severe postoperative pain following bunionectomy surgery. Pain Med (2013) 0.75

Analgesic use by ageing and elderly patients with chronic non-malignant pain: a qualitative study. Int J Clin Pharm (2017) 0.75

Patient Preferences for Pain Management in Advanced Cancer: Results from a Discrete Choice Experiment. Patient (2017) 0.75

Hemorrhagic and thrombotic events associated with generic substitution of warfarin in patients with atrial fibrillation: a retrospective analysis. Ann Pharmacother (2011) 1.61

The costs of warfarin underuse and nonadherence in patients with atrial fibrillation: a commercial insurer perspective. J Manag Care Pharm (2013) 1.03

Costs of gastrointestinal events after outpatient opioid treatment for non-cancer pain. Ann Pharmacother (2010) 0.98

The effects of galantamine treatment on caregiver time in Alzheimer's disease. Int J Geriatr Psychiatry (2003) 0.92

Anticoagulation therapy for patients with non-valvular atrial fibrillation: comparison of decision analytic model recommendations and real-world warfarin prescription use. Am J Cardiovasc Drugs (2012) 0.92

Treatment with galantamine and time to nursing home placement in Alzheimer's disease patients with and without cerebrovascular disease. Int J Geriatr Psychiatry (2009) 0.89

Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis. BMC Health Serv Res (2014) 0.87

Burden of opioid-associated gastrointestinal side effects from clinical and economic perspectives: a systematic literature review. J Opioid Manag (2010) 0.86

Optimal dosing of galantamine in patients with mild or moderate Alzheimer's disease: post Hoc analysis of a randomized, double-blind, placebo-controlled trial. Drugs Aging (2009) 0.81

Cost-effectiveness analysis of tapentadol immediate release for the treatment of acute pain. Clin Ther (2010) 0.80

Long-term treatment of patients with Alzheimer's disease in primary and secondary care: results from an international survey. Curr Med Res Opin (2009) 0.77

Bowel function after tapentadol and oxycodone immediate release (IR) treatment in patients with low back or osteoarthritis pain. Clin J Pain (2013) 0.76

Health-Related Quality-of-Life Outcomes in Patients Treated with Push-Pull OROS Hydromorphone versus Extended-Release Oxycodone for Chronic Hip or Knee Osteoarthritis Pain: A Randomized, Open-Label, Parallel-Group, Multicenter Study. Patient (2008) 0.76

Use of pregnancy counselling services in Australia 2007-2012. Aust N Z J Public Health (2015) 0.76

Review of economics and cost-effectiveness analyses of anticoagulant therapy for stroke prevention in atrial fibrillation in the US. Ann Pharmacother (2013) 0.76

Drug therapy for Alzheimer's disease. CMAJ (2004) 0.75

Review of challenges in optimizing oral anticoagulation therapy for stroke prevention in atrial fibrillation. Am J Cardiovasc Drugs (2013) 0.75